Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 study comparing NVA237 to tiotropium in patients with chronic obstructive pulmonary disease to evaluate efficacy, safety, and tole…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 pilot study evaluating the ROX Anastomotic Coupler System in patients with Chronic Obstructive Pulmonary Disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks. [Phase 3]
Phase 3 trial assessing the efficacy and safety of adding fluticasone propionate/salmeterol to umeclidinium powder in COPD over 12 weeks.
-
FDA approval · 2014-04-17FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC, indicating a lab…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks [Phase 3]
Phase 3 trial assessing adding Fluticasone Propionate/Salmeterol to umeclidinium for COPD over 12 weeks; results completed with posted data …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-04-16Clinical Trial Update: Effects of Aquatic Physical Training Program on Cardiorespiratory Variables in Patients With COPD [NA]
A clinical trial evaluating an aquatic physical training program for cardiorespiratory outcomes in chronic obstructive pulmonary disease; cu…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial in chronic obstructive pulmonary disease evaluating the efficacy and safety of NVA237 has completed, with results posted on …
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases [NA]
A completed clinical trial evaluated the Oxymizer oxygen-conserving device for its effect on endurance time in patients with chronic lung di…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Development of the Partial Pressure of Carbon Dioxide During Exercise and at Night in Patients With Chronic Obstructive Pulmonary Disease (COPD) IV [NA]
This clinical trial update reports a completed study evaluating how partial pressure of carbon dioxide changes during exercise and at night …
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A completed clinical study evaluating how rehabilitation affects muscle fibre composition and capillary networks in patients with chronic ob…
-
CLINICAL_TRIALS research · 2014-04-15Clinical Trial Update: Downhill Walking Training in COPD [NA]
KU Leuven is conducting a trial evaluating downhill walking training in chronic obstructive pulmonary disease. The current trial status is u…
-
FDA approval · 2014-04-14FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline.
-
FDA approval · 2014-04-14FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) from GlaxoSmithKline LLC. The approval updates or exp…
-
FDA approval · 2014-04-14FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application to allow Prasco Laboratories to market Fluticasone Propionate Diskus.
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder [Phase 1]
A Phase 1 study in COPD patients evaluated safety, tolerability, and pharmacokinetics after single inhaled doses of ciprofloxacin (50 mg and…
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: An Coach-based Intervention Study of an Extended Discharge Planning Program on Patients With COPD [NA]
A clinical trial update on a coach-based extended discharge planning program for chronic obstructive pulmonary disease, sponsored by Nationa…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B [Phase 3]
Phase 3 trial update for a dual bronchodilator treatment in COPD patients; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection [Phase 4]
Phase 4 study evaluating tiotropium 18 mcg in chronic obstructive pulmonary disease patients with a concurrent respiratory infection; result…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Patient -Ventilator Interaction in Chronic Respiratory Failure [Phase 2]
Phase 2 trial update reporting completion of a study on patient-ventilator interaction in chronic respiratory failure, including chronic hyp…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III) [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pulmonary deposition, and pharmacokinetics/pharmacodynamics of inhaled ciprofloxacin i…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
Phase 1 study to evaluate safety and pharmacokinetics of inhaled ciprofloxacin in patients with moderate to severe chronic obstructive pulmo…
-
CLINICAL_TRIALS withdrawal · 2014-03-27Clinical Trial Update: Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis [Phase 2]
Phase 2 trial evaluating 4-week treatment with BIBW 2948 BS in chronic obstructive pulmonary disease with chronic bronchitis; the study has …
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial evaluating the effect of statins in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 randomized, double-blind trial in chronic obstructive pulmonary disease evaluated the safety and tolerability of GSK573719/GW64244…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects [Phase 1]
Phase 1 study evaluating the effect of GS-5737 on mucociliary clearance in healthy subjects; the trial sponsored by Gilead Sciences has been…